It is a filthy chart though Van I like it. They say chart reading is a lot like viewing Pornography -- you know a good one when you see it. I do a Raw Rolling paper uptrend and get $26.60!!!!
I can't figure out that placement of the 608K shares. ____________________ On February 11, 2021, the Company consummated the closing of a private placement offering, whereby pursuant to the Purchase Agreement entered into by the Company and the Investors, the Company sold to such Investors an aggregate of 608,696 shares of Common Stock, for an aggregate purchase price of $ 14,000,008.00. The purchase price was funded on February 11, 2021 (the “Closing Date”) and resulted in net proceeds to the Company of approximately $13.4 million. ____________________ So this private placement.... someone bought for $23/share? I bet they're pissed. Hmmmm. Ya gotta think whoever plopped down $14M @ $23/share did some DD and liked the story.
I had trouble with that as well I read it as un priced as of yet. Cause it has not come to market. I read some chatter on the Yahoo board and folks are worried about a secondary--- Here are some other thoughts- 13 hours ago Up a buck in after hours. Shorts are gonna lose same. 2 days ago Bought 3 call options to hit 12.50 by mid June!!! Bullish 18 hours ago My $16 options are up 1169% !!!! Bullish 4 days ago August QTR should have revenue between 20-25 million. November QTR should have revenue between 25-30 million and that should be break even for Operating Profit. Feb 2022 QTR will be Profitable QTR with revenue of 30-40 million. Insider buying should be soon. Year 2022 and this stock is 35 or more. 2 days ago LFMD has been rising nicely last 5 trading days. We are up over 60% from recent low. Shorts seem not to be able to keep the price down.I expect to see $14 end of next week. With high volume, rising institutional ownership, insider buying and many more eyballs on this it is highly probable. Bullish
Stoney!!!! Look at our beloved Roblox. I told ya. It just took an extra week. All time high. $84.50 Your kid could have went to Princeton but you had to buy that other stupid stock. Acme Community College now.
Danimer Scientific projections 'wildly overstated,' Spruce Point says 09:40 DNMR Short-selling firm Spruce Point Capital Management released a follow-up report on Danimer Scientific. A recently released Freedom of Information Act request from the Kentucky Department of Environmental Protection provides evidence that suggests Danimer's "production figures, its pricing, and rosy financial projections are wildly overstated." Monthly Kentucky polyhydroxyalkanoate production figures have been restated by up to 100% after coming public and Danimer's PHA average selling price appears to be 30% to 42% below management's claims, Spruce Point writes in a report posted on its website. Moreover, Danimer's recently reported production figures "are so far below their actual capacity, that it calls into question why is Danimer telling investors it needs hundreds of millions of dollars in capacity expansion?" Shares of Danimer Scientific are down 27c to $20.02 in early trading. R
I GOT OUT OF SNAP AT $57.45.... YEA I screwed the RBLX trade up... The market is at an interesting intersection. The Fed has let it be known that they will talk about taking away the punch bowl if things continue as is... rather weak. So the rational is there is just enough time to rush in and have a little more fun before... Jackson Hole Massacre. It happened this way once before and it sure feels like we are on the same glide path.
Probably time to start watching these guys again... The $4 stk I sold at $8 -- They have proven 100% that they re for real. Amyris, Inc. (AMRS)<---- NasdaqGS - NasdaqGS Real Time Price. Currency in USD $13.75+0.17 (+1.25%) As of 11:49AM EDT. Market open. Amyris and Ingredion Partner to Manufacture and Market Sugar Reduction and Fermentation-Based Food Ingredients Ingredion Incorporated May 3, 2021· This got little notice, AMRS didn't even highlight it on their page- I happen to own INGR. EMERYVILLE, Calif. and WESTCHESTER, Ill., May 03, 2021 (GLOBE NEWSWIRE) --Amyris, Inc.(Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that it has signed an agreement with Ingredion Incorporated(NYSE: INGR), a leading global ingredient solutions provider to the food and beverage industry, for the exclusive licensing of Amyris’s zero-calorie, nature-based, fermented Reb M sweetener. In addition, the agreement includes an Ingredion minority ownership stake in the Amyris Brazilian manufacturing facility that is currently under construction. The combination of Amyris’s leading synthetic biology technology platform to develop, scale and produce fermentation-based products with Ingredion’s global market and customer reach, formulation capabilities and commercial teams will accelerate the availability and adoption of zero-calorie, nature-based sweeteners and other clean labeled fermentation-based food ingredients to the world’s leading food and beverage companies. Ingredion, via its PureCirclesubsidiary, will become the exclusive global business-to-business commercialization partner for Amyris’s sugar reduction technology that includes fermented Reb M. The parties will enter into an R&D collaboration agreement to create and advance the development of sustainably sourced, zero-calorie, nature-based sweeteners and potentially other types of fermentation-based food ingredients.